KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $14.9M of Kymera Therapeutics, Inc.
Sold$14,912,376
$42.20Price
353,357Shares
−30%Stake
What KYMR did after the filing
- The stock from Thu, Mar 14 open, $41.62
- −19.8%
- S&P 500, same days
- −1.4%
Measured over 30 trading days, to the Apr 26 close.
Traded Mon, Mar 11. Filed Wed, Mar 13, 7:52 PM ET, after the close. Returns use the Mar 14 open and the Apr 26 close. Not investment advice.